Processing, please wait...


Industry representative
United Kingdom
Chris Spooner was appointed CEO of Sinclair Pharma in December 2009. He has 15 years’ experience in analysing and investing in life science companies, having been a top-rated pharmaceuticals analyst at various investment banks, including JP Morgan, Deutsche Bank, Donaldson Lufkin & Jenrette and Bank of America. Prior to joining Sinclair he was the founding partner and CEO of HealthCor Management UK LLP, the European division of HealthCor LP, a leading New York based specialist healthcare fund. He holds an MA in Economics from King’s College, Cambridge.
read more
add item add Chris SPOONER

Chris SPOONER's main interests